Table 1 Clinical characteristics of the subjects
Variables | n = 169 |
|---|---|
Age, year | 69.5 ± 9.2 |
Men, n (%) | 104 (61.5) |
Body mass index, kg/m2 | 24.3 ± 3.3 |
Systolic blood pressure, mm Hg | 127.7 ± 14.1 |
Diastolic blood pressure, mm Hg | 74.8 ± 9.8 |
Heart rate, bpm | 68.8 ± 10.2 |
Total cholesterol, mg/dL | 189.3 ± 33.1 |
Triglycerides, mg/dL | 137.7 ± 125.2 |
HDL cholesterol, mg/dL | 58.9 ± 14.4 |
LDL cholesterol, mg/dL | 106.1 ± 28.6 |
Glucose, mg/dL | 106.7 ± 24.3 |
HbA1c, % | 5.4 ± 0.6 |
Creatinine, mg/dL | 0.86 ± 0.38 |
eGFR, ml/min/1.73 m2 | 67.3 ± 17.9 |
Smoker, n (%) | 86 (51.2) |
Complications, n (%) | |
Dyslipidemia | 131 (78.0) |
Diabetes mellitus | 46 (27.4) |
Coronary heart disease | 33 (19.8) |
Cerebrovascular disease | 27 (16.1) |
Medication use, n (%) | |
Calcium channel blockers | 138 (82.6) |
ARBs/ACEIs | 125 (74.9) |
β-blockers | 19 (11.4) |
Diuretics | 37 (22.2) |
Antiplatelet drugs | 39 (23.4) |
Statins | 94 (56.3) |
Antidiabetic drugs | 31 (18.6) |
Home blood pressure monitoring | |
Morning systolic blood pressure, mm Hg | 129.4 ± 11.6 |
Evening systolic blood pressure, mm Hg | 123.5 ± 11.5 |
Night-time systolic blood pressure, mm Hg | 115.4 ± 10.8 |
